Clincosm LogoSign in Get a demo

brca2 mutation

Showing 1 - 25 of 46
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Genetic Disease, BRCA2 Mutation Trial (blood sample for BRCA2 mutation detection)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • blood sample for BRCA2 mutation detection
  • (no location specified)
Jun 1, 2023

Endocrine Disruptors and Life STILe in Breast Cancer Development

Recruiting
  • Breast Cancer
  • +5 more
    • Roma, Italy
      Alessandra Fabi
    Feb 25, 2023

    Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

    Not yet recruiting
    • Metastatic Solid Tumor
    • +4 more
    • San Francisco, California
      University of California, San Francisco
    Jan 12, 2023

    Registry of Subjects at Risk of Pancreatic Cancer

    Recruiting
    • Familial Pancreatic Cancer
    • +6 more
    • MRCP
    • Endoultrasonography
    • Rozzano, Milan, Italy
    • +3 more
    Jan 12, 2023

    Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)

    Recruiting
    • Pancreatic Adenocarcinoma Metastatic
    • +14 more
    • Boston, Massachusetts
    • +1 more
    Dec 6, 2022

    BRCA1 Mutation, BRCA2 Mutation, Ovarian Cancer Trial in Providence (Talazoparib Oral Capsule)

    Active, not recruiting
    • BRCA1 Mutation
    • +4 more
    • Talazoparib Oral Capsule
    • Providence, Rhode Island
    • +1 more
    Nov 30, 2022

    An Intervention to Increase Genetic Testing in Families Who May

    Recruiting
    • BRCA1 Mutation
    • +21 more
    • Intervention Arm At-risk Relative/ARR Contacts
    • +5 more
    • Basking Ridge, New Jersey
    • +7 more
    Nov 22, 2022

    Searching for Novel Germline Mutations in Lobular Breast Cancer

    Recruiting
    • Lobular Breast Carcinoma
    • +3 more
    • Illumina panel
    • Milan, Italy
      European Institute of Oncology
    Sep 12, 2022

    Investigate Adaptation and Evolution of Ovarian High-grade

    Recruiting
    • Ovarian Cancer
    • +6 more
      • Bristol, United Kingdom
      • +10 more
      Sep 8, 2022

      BRCA1/2 Flu Vaccine

      Active, not recruiting
      • BRCA1 Mutation
      • BRCA2 Mutation
      • Seasonal influenza vaccine
      • Philadelphia, Pennsylvania
        University of Pennsylvania
      Aug 16, 2022

      BRCA1 Mutation, BRCA2 Mutation Trial in New York, Durham, Houston (Family Letter (Standard of Care), Educational Video, Mailed

      Recruiting
      • BRCA1 Mutation
      • BRCA2 Mutation
      • Family Letter (Standard of Care)
      • +3 more
      • New York, New York
      • +2 more
      Aug 12, 2022

      Prostate Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (Olaparib, LHRH agonist)

      Not yet recruiting
      • Prostate Cancer
      • +4 more
      • (no location specified)
      Aug 10, 2022

      Triple Negative Breast Tumors, Triple Negative Breast Cancer, Breast Tumors Trial (Pembrolizumab, Paclitaxel, Carboplatin)

      Not yet recruiting
      • Triple Negative Breast Neoplasms
      • +7 more
      • (no location specified)
      Aug 1, 2022

      Nipple-sparing Mastectomy, Prophylactic Mastectomy, Breast Cancer Trial in Taoyuan (da Vinci SP? Single-port System)

      Recruiting
      • Nipple-sparing Mastectomy
      • +4 more
      • da Vinci SPⓇ Single-port System
      • Taoyuan, Taiwan
        Chang Gung Memeorial Hospital, Linkou Medical Center
      Jul 29, 2022

      BRCA Founder OutReach (BFOR) Study

      Active, not recruiting
      • BRCA1 Mutation
      • BRCA2 Mutation
      • BFOR Digital Health solution/Web Portal
      • Los Angeles, California
      • +4 more
      May 11, 2022

      Breast Cancer Female, BRCA1 Mutation, BRCA2 Mutation Trial in Paris, Clermont-Ferrand, Beaumont (liquid biopsy)

      Recruiting
      • Breast Cancer Female
      • +2 more
      • liquid biopsy
      • Paris, Ile De France, France
      • +5 more
      Mar 24, 2022

      An Imaging Study of FCH-PET-CT in Prostate Cancer andBRCA Gene

      Recruiting
      • Prostate Cancer
      • +2 more
      • MRI pelvis or CT imaging
      • +2 more
      • London, Sutton, Surrey, United Kingdom
        Cancer Genetics Unit, Royal Marsden Hospital
      Mar 30, 2022

      HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer

      Completed
      • Epithelial Ovarian Cancer
      • +6 more
      • Evaluation of homologous recombination deficiency score
      • Beijing, Beijing, China
        Lei Li
      Mar 26, 2022

      Gynecologic Cancer, Breast Cancer, BRCA1 Mutation Trial in New York (Web-based family health history tool)

      Active, not recruiting
      • Gynecologic Cancer
      • +3 more
      • Web-based family health history tool
      • New York, New York
        Weill Cornell Medicine
      Feb 23, 2022

      TNBC - Triple-Negative Breast Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (olaparib, Durvalumab)

      Not yet recruiting
      • TNBC - Triple-Negative Breast Cancer
      • +2 more
      • (no location specified)
      Jan 12, 2022

      Single Port Robot-assisted Nipple Sparing Mastectomy (SPrNSM)

      Completed
      • Anatomic Stage IA Breast Cancer AJCC v8
      • +11 more
        • Dallas, Texas
          UT Southwestern Medical Center
        Jan 20, 2022

        Prostatic Tumor, Prostate Cancer, BRCA2 Mutation Trial in Boston (Prostate cancer screening)

        Recruiting
        • Prostatic Neoplasm
        • +7 more
        • Prostate cancer screening
        • Boston, Massachusetts
          Massachusetts General Hospital
        Nov 30, 2021

        Dietary Modification, BRCA1 Mutation, BRCA2 Mutation Trial in Milano (Dietary intervention)

        Completed
        • Dietary Modification
        • +3 more
        • Dietary intervention
        • Milano, Italy
          Fondazione IRCCS Istituto Nazionale dei Tumori
        Sep 27, 2021

        Depression and Body Image Distress Following Mastectomy With

        Completed
        • Breast Cancer
        • +2 more
        • Psychosocial variables
        • Boston, Massachusetts
          Massachusetts General Hospital
        Aug 5, 2021

        Metastatic Breast Cancer, Locally Advanced Breast Cancer, Advanced Breast Cancer Trial in Philadelphia (Palbociclib, Olaparib,

        Recruiting
        • Metastatic Breast Cancer
        • +4 more
        • Philadelphia, Pennsylvania
          Abramson Cancer Center of the University of Pennsylvania
        Jul 20, 2021